ArticleFrontiers in cellular neuroscience2021

Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients - Brief Research Report.

Adriel S Moraes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.